Skip to main content
# Title Department Research Year
101 Pharmaceutical interventions for drug-related problems in the neonatal intensive care unit: incidence, types, and acceptability Department of Clinical Pharmacy 2024
102 New series of 4, 6-diaryl pyrimidines: facile synthesis and antiproliferative activity as dual EGFR/VEGFR-2 inhibitors Department of Pharmaceutical Organic Chemistry 2024
103 First electrochemical nanosensor for ultrasensitive quantification of MET inhibitor, capmatinib based on carbon nanofiber networks incorporated with hybrid nanofiller nanogold-loaded porous acetylene black Department of Pharmaceutical Analytical Chemistry 2024
104 Computational Design of Azine-Linked Hybrids of 2-Indolinone-Thiazolodine Scaffold as Novel and Promising Quorum Sensing Inhibitors Department of Medicinal Chemistry 2024
105 Design, synthesis and mechanistic anticancer activity of new acetylated 5-aminosalicylate-thiazolinone hybrid derivatives Department of Pharmaceutical Organic Chemistry 2024
106 Comparative study of Lepidium sativum orally administered seeds, hydrogel and atorvastatin on obesity of rats fed on a high fat diet Department of Industrial Pharmacy 2024
107 Dual-Modulation ratiometric fluorescence strategy for cobalt and topotecan detection using Red-Emissive carbon dots Department of Pharmaceutical Analytical Chemistry 2024
108 Curcumin-loaded gold nanoparticles with enhanced antibacterial efficacy and wound healing properties in diabetic rats Department of Pharmaceutics 2024
109 An overview of the most used synthetic pathways of 1,2,4-triazolo[1,5-a] pyrimidines Department of Medicinal Chemistry 2024
110 The promising antioxidant effects of lignans: Nrf2 activation comes into view Department of Pharmacognosy 2024